Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/30/2012US8299105 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
10/30/2012US8299104 Melanin hormone antagonist; therapy for obesity, type-2 diabetes
10/30/2012US8299103 Compounds which selectively modulate the CB2 receptor
10/30/2012US8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
10/30/2012US8299101 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators
10/30/2012US8299100 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability
10/30/2012US8299099 Heteroaryl derivatives as CFTR modulators
10/30/2012US8299098 Piperidinyl derivative as a modulator of chemokine receptor activity
10/30/2012US8299097 Methods for treating inflammatory disorders
10/30/2012US8299096 Method for treating pulmonary diseases using rho kinase inhibitor compounds
10/30/2012US8299095 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299093 Small molecule inhibitors of retroviral assembly and maturation
10/30/2012US8299092 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one and methods of their preparation and utilization
10/30/2012US8299091 Aminoisoquinoline thrombin inhibitor with improved bioavailability
10/30/2012US8299090 Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
10/30/2012US8299089 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
10/30/2012US8299088 Compositions and methods for treating cancer
10/30/2012US8299087 Compositions and methods for inhibition of the JAK pathway
10/30/2012US8299086 Pyrimidine derivatives
10/30/2012US8299085 Quinazoline derivatives
10/30/2012US8299084 Piperidine inhibitors of Janus kinase 3
10/30/2012US8299083 PDE5 inhibitor compositions and methods for treating cardiac indications
10/30/2012US8299082 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
10/30/2012US8299081 Methods for treating drug resistant cancer
10/30/2012US8299080 Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
10/30/2012US8299078 Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
10/30/2012US8299077 Inhibitors of Bruton's tyrosine kinase
10/30/2012US8299075 Substituted thiomorpholine derivatives
10/30/2012US8299074 P38 MAP kinase inhibitors
10/30/2012US8299073 P38 MAP kinase inhibitors
10/30/2012US8299072 Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof
10/30/2012US8299071 Substituted pyridine derivatives
10/30/2012US8299070 Indole compounds and pharmaceutical use thereof
10/30/2012US8299069 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1H-pyrrol[3,2-C]pyridine-4(5H)-one compounds and use as protein kinase inhibitors
10/30/2012US8299068 Therapeutically active cyclopentanes
10/30/2012US8299067 5-demethoxyfumagillol and derivatives thereof
10/30/2012US8299066 Compounds having NPY Y5 receptor antagonistic activity
10/30/2012US8299065 Antibacterial condensed thiazoles
10/30/2012US8299064 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
10/30/2012US8299063 Amido-thiophene compounds and their use
10/30/2012US8299062 Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
10/30/2012US8299061 Inhibitors of diacylglycerol acyltransferase
10/30/2012US8299060 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
10/30/2012US8299059 Crystalline compound and a process for its preparation
10/30/2012US8299057 Substituted indazole derivatives active as kinase inhibitors
10/30/2012US8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
10/30/2012US8299055 8-substituted isoquinoline derivative and the use thereof
10/30/2012US8299054 Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
10/30/2012US8299053 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
10/30/2012US8299052 Pharmaceutical compositions and methods for improved bacterial eradication
10/30/2012US8299051 Beta-lactamase inhibitory compounds
10/30/2012US8299050 Method for treating uterine fibroids
10/30/2012US8299049 Compositions comprising an extract of Tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases
10/30/2012US8299048 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
10/30/2012US8299047 2-alkyl-cycloalk(en)yl-carboxamides
10/30/2012US8299040 Treating cell proliferative disorders using antisense and/or RNA interfering agents; suppression of protein kinase C and/or transferase activity
10/30/2012US8299039 Modulation of growth hormone receptor expression and insulin-like growth factor expression
10/30/2012US8299038 Methods and compositions for treating hepatitis C virus
10/30/2012US8299037 Feed or pharmaceutical composition comprising apramycin or an adequate salt thereof
10/30/2012US8299035 10a-azalide compound having 4-membered ring structure
10/30/2012US8299034 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway
10/30/2012US8299033 Iodo-hexose compounds useful to treat cancer
10/30/2012US8299014 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues
10/30/2012US8298817 Vector
10/30/2012US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them
10/30/2012US8298595 Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
10/30/2012US8298589 Nitrite formulations and their use as nitric oxide prodrugs
10/30/2012US8298583 Film delivery system for tetrahydrolipstatin
10/30/2012US8298581 Matrix compositions for controlled delivery of drug substances
10/30/2012US8298580 Sustained-release formulations of topiramate
10/30/2012US8298577 Effervescent oral opiate dosage forms and methods of administering opiates
10/30/2012US8298576 Sustained-release formulations of topiramate
10/30/2012US8298575 consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use
10/30/2012US8298573 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
10/30/2012US8298572 Adhesive pharmaceutical preparation containing bisoprolol
10/30/2012US8298570 Sustained release intraocular implants and related methods
10/30/2012US8298565 Polymer coatings containing drug powder of controlled morphology
10/30/2012US8298563 Polymer no donor predrug nanofiber coating for medical devices and therapy
10/30/2012US8298558 Homogeneous granulation; a wet milled first active ingredient, a second active ingredient pulverized into coarser particles than the first active ingredient; agricultural formulations
10/30/2012US8298556 Methods and related compositions for the non-surgical removal of fat
10/30/2012US8298548 Compositions for improving the health and appearance of skin
10/30/2012US8298543 Identification and application of antibiotic synergy
10/30/2012US8298537 Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012US8298521 Treatment for eye disorder
10/30/2012US8298518 Method of enhancing hair growth
10/30/2012US8298515 Vitamin formulation
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2684402C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
10/30/2012CA2683318C Diazo bicyclic smac mimetics and the uses thereof
10/30/2012CA2682504C Aurora kinase modulators and method of use
10/30/2012CA2679915C Novel sulfonated sugar compound and use thereof as medicine
10/30/2012CA2675528C Oral disinfectant, and food additive comprising the disinfectant
10/30/2012CA2674075C Antifolate agent combinations in the treatment of cancer
10/30/2012CA2669695C Tetrahydropyridinyl compounds for inflammation and immune-related uses
10/30/2012CA2620380C Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
10/30/2012CA2602950C Methods for the treatment of central nervous system injury via a tapered administration of progesterone
10/30/2012CA2598962C Crystalline acat inhibitor
10/30/2012CA2581730C New histone deacetylases inhibitors
1 ... 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 ... 7860